Healthcare and pharmaceuticals form a core part of MFIM’s deep advisory expertise. Over the last decade, we have advised on many significant and innovative transactions, including the largest cross-border pharmaceutical transaction in China. We maintain a strong network of long-term relationships with the largest domestic and international healthcare companies, innovative players in specialized verticals, healthcare-focused financial sponsors, and leading investment banks worldwide.
Our team of professionals, many with advanced life science degrees and backgrounds in the healthcare industry, has first-hand knowledge of sector-specific strategies, challenges, and solutions. Our extensive transaction experience – from oncology, to women’s health, to traditional Chinese medicine – allows us to provide tailored solutions and add significant value to each engagement.
Our expertise spans the entire value chain of pharmaceuticals, including generics and patented drugs, prescription medication and OTC, CRO and CRAM, as well a large range of medical devices and healthcare related services.
